Is a complete LON/0Q77 research report available?

No complete published report is available for lon/0Q77 (LON/0Q77) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0Q77 (LON/0Q77)

London Stock Exchange: LON/0Q77 · EUR

€0.74

-0.00 (-0.1%)· Recorded snapshot

Market cap	50.3M
Revenue (ttm)	1M
Net income (ttm)	-1.4M
EPS (ttm)	-€0.03
Volume	8
Beta	1.17

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1M
Net income (ttm): -1.4M
EPS (ttm): -€0.03
Market cap: 50.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-09 02:00 UTC

All LON/0Q77 indicators

Market & fundamental data

Available fields

183

Groups with data

Currency

EUR

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	36
Employees Change	-3%
Employees Change Percent	-7.69
Enterprise value	EUR 58.2M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	19.25
Industry PE Fwd	15.61
Isin	FR0010557264
Last refreshed	2026-09-09
Market cap	EUR 50.3M
Price	EUR 0.74
Price currency	EUR
Rev Per Employee	33,037.61x
Sector	Healthcare
Sector PE	21.51
Sector PE Fwd	13.73
Sic	2834
Symbol	lon/0Q77
Website	https://www.ab-science.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.7%
EV/EBIT	106.17x
EV/EBITDA	75.63x
EV/Sales	57.79x
FCF yield	-7.93%
P/B ratio	-3.35x
P/S ratio	49.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	54.43%
EBITDA Margin	63.46%
Gross margin	83.3%
Gross Profit	EUR 853,181
Gross Profit Growth	-21.63%
Gross Profit Growth Q	5.89%
Gross Profit Growth3 Y	1.8%
Gross Profit Growth5 Y	-8.37%
Net Income	EUR -1.4M
Net Income Growth Quarters	1%
Net Income Growth Years	9%
Pretax Margin	-132.62%
Profit Margin	-132.62%
Profit Per Employee	EUR -43,816
Profitable Quarters	EUR 1
ROA	1.67
Roa5y	-25.2
ROCE	6.58

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-24.85%
Cagr1y	-38.53%
Cagr3y	-37.51%
Cagr5y	-43.7%
EPS Growth Quarters	1
EPS Growth Years	9
Revenue Growth	9.52x
Revenue Growth Q	28.71x
Revenue Growth Qo Q	27.96x
Revenue Growth Quarters	1x
Revenue Growth Years	3x
Revenue Growth3 Y	7.01x
Revenue Growth5 Y	-5.8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.05
Assets	EUR 21.4M
Cash	EUR 8.9M
Current Assets	EUR 12.2M
Current Liabilities	EUR 12.7M
Debt	EUR 17M
Debt EBITDA	EUR 21.68
Debt FCF	EUR -4.26
Equity	EUR -15M
Interest Coverage	0.5
Liabilities	EUR 36.4M
Long Term Assets	EUR 9.2M
Long Term Liabilities	EUR 23.7M
Net Cash	EUR -8.1M
Net Cash By Market Cap	EUR -16.08
Net Debt EBITDA	EUR 12.44
Tangible Book Value	EUR -16.4M
Tangible Book Value Per Share	EUR -0.22
WACC	9.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.96
Inventory Turnover	1.19
Net Working Capital	EUR -8.7M
Quick ratio	0.92
Working Capital	EUR -535,637
Working Capital Turnover	EUR -0.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-94.25%
1Y total return	-38.51%
200-day SMA	1.09
3Y total return	-75.61%
50-day SMA	0.71
50-day SMA vs 200-day SMA	50under200
5Y total return	-94.34%
All Time High	21.43
All Time High Change	-96.53%
All Time High Date	2020-12-24
All Time Low	0.54
All Time Low Change	37.78%
All Time Low Date	2026-07-31
ATR	0.04
Beta	1.17
Ch YTD	-51.37
High	0.74
High52	1.65
High52 Date	2025-10-15
High52ch	-54.91%
Low	0.74
Low52	0.54
Low52 Date	2026-07-31
Low52ch	37.78%
Ma50ch	4.38%
Price vs 200-day SMA	-31.99%
RSI	54.01
RSI Monthly	36.26
RSI Weekly	39.98
Sharpe ratio	-0.63x
Sharpe Ratio3y	-0.38x
Sharpe Ratio5y	-0.4x
Sortino ratio	-0.91
Sortino Ratio3y	-0.58
Sortino Ratio5y	-0.58
Total Return	-14.94%
Tr YTD	-51.37
Tr1m	-9.16%
Tr1w	6.59%
Tr3m	-19.83%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,821,545%
Net Borrowing	-1,645,824.7
Shares Insiders	48.48%
Shares Institutions	0%
Shares Qo Q	9.96%
Shares Yo Y	14.94%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -5.8M
Adjusted OCF	-5,565,739
Average Volume	1,008.05x
Bv Per Share	-0.21
CAPEX	EUR -246,009
Ch10y	-94.25
Ch1m	-9.16
Ch1w	6.59
Ch1y	-38.51
Ch3m	-19.83
Ch3y	-75.61
Ch5y	-94.34
Ch6m	-42.06
Change	-0.13%
Change From Open	0
Close	0.75
Days Gap	-0.13
Depreciation Amortization	91,005.4
Dollar Volume	5.95
Earnings Date	2026-09-30
EBIT	EUR 557,446
EBITDA	EUR 649,918
EPS	EUR -0.03
F Score	3
FCF	EUR -4M
FCF EV Yield	-6.85x
Financing CF	5,835,302
Fiscal Year End	December
Founded	2,001
Investing CF	-195,412
Is Primary Listing	0
Last Earnings Date	2026-05-13
Last Report Date	2025-12-31
Ma150	1.05
Ma150ch	-28.87%
Ma20	0.72
Ma20ch	3.61%
Net CF	1,898,283
Next Earnings Date	2026-09-30
Open	0.74
Ppne	855,107.7
Price Date	2026-09-08
Price EBITDA	EUR 77.37
Relative Volume	0.01x
Revenue	1,024,166x
SBC By Revenue	178.11x
Share Based Comp	1,824,132
Tr6m	-42.06%
Volume	8

LON/0Q77 (LON/0Q77)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0Q77

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0Q77 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0Q77

Frequently asked questions